Dr. Michaelis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
# Neoplast
Milwaukee, WI 53226Phone+1 414-805-4600Fax+1 414-805-6805
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 2003 - 2006
- Brigham and Women's HospitalResidency, Internal Medicine, 2000 - 2003
- Harvard Medical SchoolClass of 2000
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- WI State Medical License 2013 - 2025
- IL State Medical License 2003 - 2014
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 40 is the new 50: reducing the need for platelet transfusions prior to lumbar puncture in adults with hematologic malignancies.Kristen Corrao, Adrian Umpierrez, Angela Treml, Aniko Szabo, Laura Michaelis
Haematologica. 2025-01-30 - The Fit Older Adult with Acute Myeloid Leukemia: Clinical Challenges to Providing Evidence-Based Frontline Treatment.Sameem M Abedin, Geoffrey L Uy, Laura C Michaelis
Blood. 2025-01-24 - 4 citationsA phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia.Guru Subramanian Guru Murthy, Antoine N Saliba, Aniko Szabo, Alexandra Harrington, Sameem Abedin
Haematologica. 2024-09-01
Press Mentions
- Caring for the Caregivers of Patients with Hematologic Malignancies Undergoing HSCTMay 26th, 2023
- COVID-19 Takes a Toll on People with Blood Cancers and DisordersDecember 11th, 2021
- Clinical Challenges: MyelofibrosisDecember 17th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: